The pharmaceutical company Petrovax Pharm and the St. Petersburg Scientific Research Institute of Vaccines and Serums (SPbSRIVS) have signed an agreement on long-term strategic cooperation in the development, production, and introduction of innovative Russian vaccines into the public healthcare practice. In the near future, the companies plan to launch the joint full production cycle of
Tagged under: , ,
On February 18-20, a tripartite meeting was held by the representatives of Russia, Nicaragua, and the leadership of PAHO/WHO in Managua, Nicaragua. As a result of the meeting, a memorandum and an agreement of intent were signed. SPbSRIVS influenza vaccine and tuberculin, as well as its production facility in Krasnoye Selo will be registered in